Dengue-2 vaccine: preparation from a small-plaque virus clone

Area of Science:

• Virology
• Vaccinology
• Infectious Diseases

Background:

• Dengue virus type 2 poses a significant global health challenge.
• Development of effective live-attenuated vaccines is crucial for dengue control.
• Previous vaccine candidates have faced challenges with thermostability and immunogenicity.

Purpose of the Study:

• To evaluate the characteristics of a live-attenuated dengue type 2 virus vaccine (S-1 clone) derived from DBS-FRhL-2 cell culture.
• To compare the vaccine candidate with its precursor (S-1 PGMK) in terms of viral replication, host restriction, and virulence.
• To assess the immunogenicity of the S-1 vaccine in non-human primates.

Main Methods:

• Passage of Dengue Type 2 Virus (S-1 clone) in DBS-FRhL-2 cell culture to generate the vaccine candidate.
• In vitro assessment of viral replicative capacity at superoptimal temperatures.
• Evaluation of viral "leakiness" at increased temperatures.
• In vitro replication assays in monkey peripheral blood leukocytes.
• Assessment of mouse virulence and monkey immunogenicity.

Main Results:

• The S-1 vaccine virus exhibited higher replicative capacity at superoptimal temperatures compared to the S-1 PGMK precursor.
• A tendency for increased viral "leakiness" was observed for the S-1 vaccine at elevated temperatures.
• Less host restriction was indicated for the S-1 vaccine in replication assays with monkey leukocytes.
• Mouse virulence remained stable after passage in DBS-FRhL-2 cells.
• A decrease in monkey immunogenicity was observed for the S-1 vaccine.

Conclusions:

• The S-1 dengue type 2 vaccine candidate possesses altered in vitro characteristics, including enhanced replication at higher temperatures and reduced host restriction.
• While mouse virulence was maintained, a notable decrease in immunogenicity in monkeys was observed.
• Cautious clinical trials in humans are warranted to further evaluate the safety and efficacy of this dengue type 2 vaccine candidate.